Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3274093

Beta release

Statistics of Response to "Optimized Alectinib Dose Regimen for Treatment of Patients With ALK-Positive NSCLC Based on Robust Pharmacometric Analyses and Clinical Evidence"
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0800
2024-0900
2024-1000